-+ 0.00%
-+ 0.00%
-+ 0.00%

Dongxing Medical announced that the company plans to increase the capital of its wholly-owned subsidiary Dongxing Huamei by 909.18,700 yuan and to Zihang Precision by 354.14,900 yuan through debt-to-equity swaps. The relevant bill was reviewed and approved by the board of directors on November 16, 2026. After the capital increase was completed, the registered capital of Dongxing Huamei increased from 50 million yuan to 140 million yuan, and Zi Hang Precision increased from 5 million yuan to 40 million yuan. The two companies are still wholly-owned subsidiaries of the company, and will not cause changes in the scope of the consolidated statement. This capital increase does not need to be submitted to the shareholders' meeting for consideration, and does not constitute a related transaction or major asset restructuring.

Zhitongcaijing·11/16/2026 08:25:09
Listen to the news
Dongxing Medical announced that the company plans to increase the capital of its wholly-owned subsidiary Dongxing Huamei by 909.18,700 yuan and to Zihang Precision by 354.14,900 yuan through debt-to-equity swaps. The relevant bill was reviewed and approved by the board of directors on November 16, 2026. After the capital increase was completed, the registered capital of Dongxing Huamei increased from 50 million yuan to 140 million yuan, and Zi Hang Precision increased from 5 million yuan to 40 million yuan. The two companies are still wholly-owned subsidiaries of the company, and will not cause changes in the scope of the consolidated statement. This capital increase does not need to be submitted to the shareholders' meeting for consideration, and does not constitute a related transaction or major asset restructuring.